“…In addition, detailed toxicological studies are necessary to decide the clinical future of this novel plant and its various active constituents as safety is a critical concern during clinical development of plant‐based medicines (Izzo, Hoon‐Kim, Radhakrishnan, & Williamson, ). In addition, physiological and biopharmaceutical parameters are often the bottleneck in the clinical translation of plant‐based medicines, which may be addressed by using various novel formulation‐based strategies (Bale, Khurana, Reddy, Singh, & Godugu, ; Godugu, Kumari, & Khurana, ; Khurana et al, ; Khurana, Saifi, & Godugu, ; Khurana, Tekula, Saifi, Venkatesh, & Godugu, ).…”